Funding for Research on Psychedelics Is ...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ... Show More

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ... Show More

In this episode, host Rachel Feltman interviews neuroscientist Kauê M. Costa, who is among Scientific American’s inaugural cohort of Young American Scientists honorees. Costa shares how being surprised by experiments has led him to new ways of thinking about learning in the brain ... Show More

As interest and support for psychedelic research grows, scientists share their hopes for the future. Learn more about your ad choices. Visit megaphone.fm/adchoices 

As companies join the hunt, can the field of mind-altering synthetic substances stay true to its original pioneering spirit of wonder, curiosity and connection? Learn more about your ad choices. Visit megaphone.fm/adchoices 

Psychedelic researchers are engaged in heated debate over whether the mind-altering effects of the drugs are necessary for realizing their therapeutic potential. Learn more about your ad choices. Visit megaphone.fm/adchoices 

James Gallagher reports on a psychedelic renaissance; a new wave of research testing hallucinogenic drugs like magic mushrooms to treat mental health conditions.There’s genuine excitement and some early encouraging evidence. A manufacturer tells James that in five years’ time, it ... Show More

Drugs like ecstasy and mushrooms have shown promise as mental health treatments, but they’re also exposing some major cracks in how scientists study the brain. Guests: Jonathan Lambert, science journalist; Boris Heifets, professor at Stanford University of Medicine; Amy Mcguire, ... Show More

There is growing support for psychedelics as performance enhancers, mood boosters, and a shortcut to therapy. The science is mixed. This episode was produced by Miles Bryan, engineered by Paul Mounsey, fact-checked by Victoria Dominguez, and edited by Matt Collette and host Sean ... Show More

What are psychedelics? How have these substances influenced human minds and culture? What exactly do they invoke in the brain and how could a renaissance of scientific study into their properties improve our lives? In this series of Stuff to Blow Your Mind episodes, Robert and Jo ... Show More

What are psychedelics? How have these substances influenced human minds and culture? What exactly do they invoke in the brain and how could a renaissance of scientific study into their properties improve our lives? In this series of Stuff to Blow Your Mind episodes, Robert and Jo ... Show More

<p>Although psychadelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this episode of BrainStuff.</p><p> </p> Learn more about y ... Show More

Although psychedelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this classic episode of BrainStuff. Learn more about your ad- ... Show More